EUVIMEDEUVIMED entdecken
Crossref

Thyroid Hormone Replacement Dosing after Bariatric Surgery in Patients with Primary Hypothyroidism And Severe Obesity: Tehran Obesity Treatment Study

Maryam Barzin, Danial Molavizadeh, Maryam Mahdavi, Alireza Khalaj, Sara Sadeghi, Majid Valizadeh, Fereidoun Azizi iD, Farhad Hosseinpanah

Thyroid® · 2024

DOI: 10.1089/thy.2024.0073 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Thyroid®, 2024. Verfasst von Maryam Barzin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Obesity Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Hypothyroidism, Thyroxine, Hormone Replacement Therapy, Obesity, Morbid. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Obesity and hypothyroidism are common medical conditions that are associated with each other. Bariatric surgery (BS) is a common approach used to achieve substantial weight loss in obese patients. However, there is limited evidence regarding the need for postsurgery levothyroxine (LT4) dose adjustment in patients with hypothyroidism undergoing BS.

Methods

This was a three-year prospective cohort study assessing postsurgery LT4 requirements with attention to body composition changes. The current study included 1030 patients with hypothyroidism, who underwent sleeve gastrectomy (SG) ( n = 707, 88.3% women) or one anastomosis gastric bypass (OAGB) ( n = 323, 92% women). Patients were followed for 36 months after surgery. A bioelectrical impedance analyzer was used for body composition assessment. LT4 requirements were assessed by generalized estimating equation (GEE) methods adjusted for weight as a time-varying covariate.

Results

During the follow-up, TSH (mIU/L) and T4 (ng/dL) measurements did not significantly change in the OAGB group over time. However, in the SG group, TSH measurement decreased over time ( p trend =

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypothyroidismThyroxineHormone Replacement TherapyObesity, MorbidBariatric SurgeryHumansFemaleAdultMaleProspective StudiesMiddle AgedIranThyrotropinTreatment OutcomeBody CompositionGastric BypassGastrectomy

Stichwörter der Autor:innen

bariatric surgeryprimary hypothyroidismsevere obesitythyroid hormone replacement dosing

Substanzen

ThyroxineThyrotropin

Autor:innen und Institutionen

  • Obesity Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • School of Medicine, Kashan University of Medical Sciences, Kashan, Iran.
  • Department of Surgery, Faculty of Medicine, Tehran Obesity Treatment Center, Shahed University, Tehran, Iran.
  • Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Fereidoun Azizi

Zitieren

APA

Barzin, M., Molavizadeh, D., Mahdavi, M., Khalaj, A., Sadeghi, S., Valizadeh, M., Azizi, F., & Hosseinpanah, F. (2024). Thyroid Hormone Replacement Dosing after Bariatric Surgery in Patients with Primary Hypothyroidism And Severe Obesity: Tehran Obesity Treatment Study. Thyroid®. https://doi.org/10.1089/thy.2024.0073

Vancouver

Barzin M, Molavizadeh D, Mahdavi M, Khalaj A, Sadeghi S, Valizadeh M, et al. Thyroid Hormone Replacement Dosing after Bariatric Surgery in Patients with Primary Hypothyroidism And Severe Obesity: Tehran Obesity Treatment Study. Thyroid®. 2024. doi:10.1089/thy.2024.0073

BibTeX
@article{Barzin2024,
  author = {Barzin, Maryam and Molavizadeh, Danial and Mahdavi, Maryam and Khalaj, Alireza and Sadeghi, Sara and Valizadeh, Majid and Azizi, Fereidoun and Hosseinpanah, Farhad},
  title = {Thyroid Hormone Replacement Dosing after Bariatric Surgery in Patients with Primary Hypothyroidism And Severe Obesity: Tehran Obesity Treatment Study},
  journal = {Thyroid®},
  year = {2024},
  doi = {10.1089/thy.2024.0073}
}
Kostenlos starten →